PhD Marko Anderluh

PhD Marko Anderluh
no.: 21456 source: ARIS

researcher – active in research organisation
01 476 95 00
  marko.anderluhat signffa.uni-lj.si
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • Croatian
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • Italian
  • Reading: Fluent
  • Writing: Functional
  • Speaking: Fluent
  • French
  • Reading: Functional
  • Writing: Basic
  • Speaking: Functional
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Keywords
Peptidomimetics, fibrinogen receptor antagonists, molecular basis of medicinal chemistry
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
1,245.17
A''
130.52
A'
483.07
A1/2
712.54
CI10
1,507
CImax
127
h10
20
A1
4.21
A3
3.71
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2019, 2020, 2021, 2022, 2023)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 106  2,000  1,679  15.84 
Scopus 107  2,110  1,798  16.8 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Edvin Purić   Bologna doctoral studies    55895 
2 PhD Matjaž Weiss   Bologna doctoral studies  10/1/2017 - 9/30/2022  50503 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
    Pharmacy  SI University of Ljubljana, Faculty of Pharmacy 2000 
Doctoral degree  Ph. D.   Pharmacy  SI University of Ljubljana, Faculty of Pharmacy 2004 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  11/1/2000  Research assistant  Researcher  Full professor 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. N1-0417  Mono- and multivalent inhibitors of galectin-8 in tumour-associated (lymph)angiogenesis (MULTIGAL-8)   3/1/2025 - 9/30/2028  PhD Marko Anderluh   824 
2. J7-4420  Selective mechanical removal of bacterial biofilms by conjugated magnetic nanoparticles   10/1/2022 - 9/30/2025  PhD Aleš Berlec   4,253 
3. J3-2517  Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants   9/1/2020 - 12/31/2023  PhD Žiga Jakopin   2,442 
4. J1-2483  Radiopharmaceuticals with antagonistic activity on CCK2R   9/1/2020 - 8/31/2023  PhD Marko Anderluh   1,164 
5. J1-1717  Development of novel Hsp90 inhibitors with anticancer activity   7/1/2019 - 6/30/2023  PhD Tihomir Tomašić   2,064 
6. J3-9256  Development of NOD2 agonists and dual NOD2/TLR7 agonistic conjugates as novel vaccine adjuvants   7/1/2018 - 6/30/2022  PhD Žiga Jakopin   3,048 
7. J1-8152  Inhibicija prenove celične stene Staphylococus aureus (Slovene)   5/1/2017 - 4/30/2020  PhD Dušan Turk   2,155 
8. L1-6745  Boj proti bakterijski rezistenci: optimizacija zaviralcev biosinteze bakterijske stene (Slovene)   7/1/2014 - 6/30/2017  PhD Stanislav Gobec   3,483 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2022 - 12/31/2027 PhD Stanislav Gobec   5,846 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2015 - 12/31/2021 PhD Stanislav Gobec   6,517 
3. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2009 - 12/31/2014 PhD Danijel Kikelj   6,386 
4. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2004 - 12/31/2008 PhD Danijel Kikelj   6,446 
5. P0-0502-0787  Farmacevtska kemija (Slovene)   1/1/1999 - 12/31/2003 PhD Danijel Kikelj   7,826 
International projects
no. Code Title Period Head
1. HORIZON-GlyCanDrug-101119601  GlyCanDrug - A training network on the design of precision therapeutics that target key glycan motifs implicated in cancer   12/1/2023 - 11/30/2027 PhD Marko Anderluh    
2. COST-CA18103 - INNOGLY    11/13/2018 - 10/7/2023    
3. COST-CA18132 GLYCONanoPROBES  Functional Glyconanomaterials for the Development of Diagnostics and Targeted Therapeutic Probes   1/1/2018 - 9/13/2023 PhD Marko Anderluh    
4. H2020-PhD4GlycoDrug-211719  Multidisciplinary European Joint Doctorate in the Design and Developmen of Glyco Drugs   1/1/2017 - 12/31/2021 PhD Marko Anderluh    
Confirmation required
Views history
Favourite